907211-31-8 Usage
Uses
Used in Pharmaceutical Synthesis:
6-Fluoro-2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid is used as a reagent in the synthesis of WAY-253752, a novel dual-acting selective serotonin reuptake inhibitor (SSRI) and 5HT1A antagonist. 6-FLUORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-3-CARBOXYLIC ACID has potential applications in the treatment of various psychiatric and neurological disorders, such as depression and anxiety, due to its unique mechanism of action.
Used in Chemical Research:
6-Fluoro-2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid can also be used as a building block in the development of new chemical entities with potential applications in various industries, such as materials science, agrochemicals, and pharmaceuticals. Its unique structure and reactivity make it a valuable tool for researchers in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 907211-31-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,7,2,1 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 907211-31:
(8*9)+(7*0)+(6*7)+(5*2)+(4*1)+(3*1)+(2*3)+(1*1)=138
138 % 10 = 8
So 907211-31-8 is a valid CAS Registry Number.
907211-31-8Relevant academic research and scientific papers
First scale-up: Problems and resolutions on the synthesis of WAY-253752, a novel, dual-acting SSRI/5HT1A antagonist
Nikitenko, Antonia,Evrard, Deborah,Sabb, Annmarie L.,Vogel, Robert L.,Stack, Gary,Young, Mairead,Lin, Melissa,Harrison, Boyd L.,Potoski, John R.
, p. 76 - 80 (2012/12/31)
An alternative synthesis of WAY-253752, 1, a novel, dual-acting SSRI/5HT1A antagonist, was developed and used for the first scale-up. Initially, the target compound was synthesized as part of a diasteromeric mixture separated by chiral preparative HPLC. The new route was designed around intermediates suitable for chiral resolution, and its conditions were successfully determined.
CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES
-
Page/Page column 36; 28, (2008/06/13)
The present invention provides cycloalkylfused indole, benzothiophene, benzofuran, and indene derivatives, and methods for using them to, for example, treat, prevent and/or ameliorate central nervous system diseases by antagonizing 5-HT1A receptors and mo
